Angelini Ventures co-leads Series A financing in Neumirna Therapeutics

8th January 2025 Uncategorised 0

Investment to support RNA therapeutics for epilepsy and neurological disorders

More: Angelini Ventures co-leads Series A financing in Neumirna Therapeutics
Source: News